Tapewire

Nasdaq · USD

TLPH

TALPHERA, INC.

Export transactions ↓
Tapewire entity
7102
SEC CIK
0001427925
Parsed reports
249

Last 12 months

Inside the activity.

5 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202640
Mar 202610
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 25, 2017 Filed Sep 27, 2017 20:54 UTC
Hamel Lawrence GChief Development Officer
SaleCommon Stock 13,827 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-17-016405 · rdgdoc.xml · nonDerivative · entry 1

Hamel Lawrence G · CIK 0001511368 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 68,504

F2 · price: The Shares were sold in a range from $3.50-$4.50

F3 · balance_after: Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan

F1 · ownership.direct: 52,125 of the Shares are held in the Hamel Revocable Living Trust

F1 · ownership.nature: 52,125 of the Shares are held in the Hamel Revocable Living Trust

Read SEC document
September 11, 2017 Filed Sep 11, 2017 21:36 UTC
ASADORIAN RAFFIChief Financial Officer
PurchaseCommon Stock 7,000 $3.24 $22,705.20
Disclosure

SEC source: 0001437749-17-015834 · rdgdoc.xml · nonDerivative · entry 1

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Read SEC document
August 24, 2017 Filed Aug 24, 2017 21:54 UTC PurchaseCommon Stock 4,800 $3.03 $14,520.00
Disclosure

SEC source: 0001437749-17-015259 · rdgdoc.xml · nonDerivative · entry 2

EDWARDS MARK G · CIK 0001190429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Read SEC document
August 24, 2017 Filed Aug 24, 2017 22:14 UTC
Angotti Vincent J.Director · Chief Executive Officer
PurchaseCommon Stock 15,000 $3.00 $45,000.00
Disclosure

SEC source: 0001437749-17-015261 · rdgdoc.xml · nonDerivative · entry 1

Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
August 22, 2017 Filed Aug 22, 2017 21:19 UTC
Palmer Pamela PDirector · Chief Medical Officer
PurchaseCommon Stock 10,000 $2.95 $29,487.00
Disclosure

SEC source: 0001437749-17-015179 · rdgdoc.xml · nonDerivative · entry 1

Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 415,801

F1 · price: This is a weighted average purchase price. Shares were purchased in the range of $2.9250 and $2.95.

F2 · balance_after: Balance includes non-reportable acquisition of 6,786 shares of Common Stock through the Company's Employee Stock Purchase Plan.

Read SEC document
August 22, 2017 Filed Aug 24, 2017 21:54 UTC PurchaseCommon Stock 200 $2.90 $580.00
Disclosure

SEC source: 0001437749-17-015259 · rdgdoc.xml · nonDerivative · entry 1

EDWARDS MARK G · CIK 0001190429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,200

Read SEC document
August 16, 2017 Filed Aug 17, 2017 13:03 UTC
ASADORIAN RAFFIChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 220,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-014929 · rdgdoc.xml · derivative · entry 1

ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,000

Underlying: Common Stock · 220,000 shares

Expires 2027-08-15

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (August 16, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 19, 2017 Filed Jun 21, 2017 20:45 UTC SaleCommon Stock 875,000 $2.40 $2,100,000.00
Disclosure

SEC source: 0001012975-17-000494 · edgar.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 4,533,728

F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
June 15, 2017 Filed Jun 15, 2017 21:17 UTC
ADAMS ADRIANDirector
GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001437749-17-011357 · rdgdoc.xml · derivative · entry 1

ADAMS ADRIAN · CIK 0001248144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 15, 2017 Filed Jun 15, 2017 21:16 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001437749-17-011356 · rdgdoc.xml · derivative · entry 1

HOFFMAN C STEVEN · CIK 0001190482 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 15, 2017 Filed Jun 15, 2017 21:15 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001437749-17-011355 · rdgdoc.xml · derivative · entry 1

Rosen Howard B · CIK 0001307068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 15, 2017 Filed Jun 15, 2017 21:15 UTC
WAN MARK ADirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001437749-17-011354 · rdgdoc.xml · derivative · entry 1

WAN MARK A · CIK 0001190472 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 15, 2017 Filed Jun 15, 2017 21:13 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001437749-17-011353 · rdgdoc.xml · derivative · entry 1

Afable Richard · CIK 0001594021 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 15, 2017 Filed Jun 15, 2017 21:13 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001437749-17-011352 · rdgdoc.xml · derivative · entry 1

EDWARDS MARK G · CIK 0001190429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
June 15, 2017 Filed Feb 7, 2019 22:33 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.30 $0.00
Disclosure

SEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 4

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2027-06-14

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer.

F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors.

F5 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
April 10, 2017 Filed Apr 11, 2017 21:29 UTC
Hamel Lawrence GChief Development Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 9,122 $0.00 Strike: $1.20 $0.00
Disclosure

SEC source: 0001437749-17-006460 · rdgdoc.xml · derivative · entry 3

Hamel Lawrence G · CIK 0001511368 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,122 shares

Expires 2017-12-05

F2 · derivative.exercise_date: Options vest as follows: 1/4 of the shares subject to the option vest on December 4, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months.

Read SEC document
April 10, 2017 Filed Apr 11, 2017 21:29 UTC
Hamel Lawrence GChief Development Officer
GrantCommon Stock 6,879 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-17-006460 · rdgdoc.xml · nonDerivative · entry 2

Hamel Lawrence G · CIK 0001511368 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,354

F1 · price: Non-reportable acquisition of 6,879 shares of Common Stock through the Company's Employee Stock Purchase Plan.

Read SEC document
April 10, 2017 Filed Apr 11, 2017 21:29 UTC
Hamel Lawrence GChief Development Officer
GrantCommon Stock 9,122 $1.20 $10,946.40
Disclosure

SEC source: 0001437749-17-006460 · rdgdoc.xml · nonDerivative · entry 1

Hamel Lawrence G · CIK 0001511368 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,475

Read SEC document
March 06, 2017 Filed Mar 7, 2017 21:35 UTC
Angotti Vincent J.Director · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 800,000 $0.00 Strike: $3.30 $0.00
Disclosure

SEC source: 0001437749-17-003950 · rdgdoc.xml · derivative · entry 1

Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2027-03-05

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (March 6, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: The shares have double-trigger acceleration on a change of control

Read SEC document
February 07, 2017 Filed Feb 10, 2017 01:53 UTC
Palmer Pamela PDirector · Chief Medical Officer
GrantCommon Stock (Right to Buy) · Derivative 132,500 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-002062 · rdgdoc.xml · derivative · entry 1

Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,500

Underlying: Common Stock · 132,500 shares

Expires 2028-02-06

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
February 07, 2017 Filed Feb 10, 2017 02:03 UTC
Hamel Lawrence GChief Development Officer
GrantCommon Stock (Right to Buy) · Derivative 79,500 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-002067 · rdgdoc.xml · derivative · entry 1

Hamel Lawrence G · CIK 0001511368 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,500

Underlying: Common Stock · 79,500 shares

Expires 2028-02-06

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
February 07, 2017 Filed Feb 10, 2017 01:57 UTC
MORRIS TIMOTHY EChief Financial Officer
GrantCommon Stock (Right to Buy) · Derivative 112,500 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-002066 · rdgdoc.xml · derivative · entry 1

MORRIS TIMOTHY E · CIK 0001191286 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 112,500 shares

Expires 2028-02-06

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
February 07, 2017 Filed Feb 10, 2017 01:57 UTC
Dasu Badri NChief Engineering Officer
GrantCommon Stock (Right to Buy) · Derivative 79,500 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-002065 · rdgdoc.xml · derivative · entry 1

Dasu Badri N · CIK 0001310803 · Chief Engineering Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,500

Underlying: Common Stock · 79,500 shares

Expires 2028-02-06

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
February 07, 2017 Filed Feb 10, 2017 01:54 UTC
Wright-Mitchell JaneChief Legal Officer
GrantCommon Stock (Right to Buy) · Derivative 79,500 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-002063 · rdgdoc.xml · derivative · entry 1

Mitchell Jane Wright · CIK 0001614568 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,500

Underlying: Common Stock · 79,500 shares

Expires 2028-02-06

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
February 07, 2017 Filed Feb 18, 2017 01:09 UTC
Rosen Howard BDirector · CEO
GrantStock Option (Right to Buy) · Derivative 366,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001437749-17-002807 · rdgdoc.xml · derivative · entry 1

Rosen Howard B · CIK 0001307068 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,000

Underlying: Common Stock · 366,000 shares

Expires 2028-02-06

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2016) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.

F3 · derivative.exercise_date: 100% Acceleration upon Change of Control.

Read SEC document
September 29, 2016 Filed Sep 30, 2016 20:32 UTC SaleCommon Stock 97,200 $3.88 $377,116.56
Disclosure

SEC source: 0001019056-16-001565 · acelrx_4.xml · nonDerivative · entry 2

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,386,410

F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor.

F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
September 28, 2016 Filed Sep 30, 2016 20:32 UTC SaleCommon Stock 119,300 $3.96 $472,380.28
Disclosure

SEC source: 0001019056-16-001565 · acelrx_4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,483,610

F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor.

F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
September 15, 2016 Filed Sep 16, 2016 20:37 UTC SaleCommon Stock 115,923 $3.63 $420,510.68
Disclosure

SEC source: 0001019056-16-001549 · acelrx_4.xml · nonDerivative · entry 2

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,602,910

F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor.

F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
September 15, 2016 Filed Sep 16, 2016 20:37 UTC SaleCommon Stock 276,927 $3.73 $1,032,300.78
Disclosure

SEC source: 0001019056-16-001549 · acelrx_4.xml · nonDerivative · entry 1

PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner

EDELMAN JOSEPH · CIK 0001164426 · 10% owner

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 5,718,833

F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor.

F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Read SEC document
June 21, 2016 Filed Feb 7, 2019 22:33 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.87 $0.00
Disclosure

SEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 3

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2026-06-20

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
June 23, 2015 Filed Feb 7, 2019 22:33 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $4.08 $0.00
Disclosure

SEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 2

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2025-06-22

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
July 24, 2014 Filed Feb 7, 2019 22:33 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $10.22 $0.00
Disclosure

SEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 1

HOFFMAN STEPHEN J · CIK 0001190418 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2024-07-23

F1 · security: Issued pursuant to the 2011 Equity Incentive Plan.

F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer.

F3 · derivative.exercise_date: Fully vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.